Related by context. Frequent words. (Click for all words.) 65 R sorafenib tablets 65 Initiate Phase 63 refractory chronic lymphocytic 63 Pivotal Phase 63 MKC# 62 post herpetic neuralgia PHN 62 Sapacitabine 62 Coadministration 60 Meets Primary Endpoint 60 Chronic Heart Failure 60 Initiates Phase II 60 Pivotal Phase III 60 NYHA Class III 60 DDP# 59 Dapagliflozin 59 liposomal formulation 59 Hypoactive Sexual Desire Disorder 59 Pirfenidone 58 placebo controlled Phase 58 plus prednisone 58 pseudobulbar affect PBA 58 metastatic castration resistant 58 TACI Ig 58 cardiovascular ischemic 58 Diabetic Macular Edema 58 Pivotal Trial 58 Microplasmin 58 Commences Phase 58 LATUDA 58 Pulmonary Arterial Hypertension 58 multicenter Phase 58 Improves Survival 58 tumor lysis syndrome 58 forodesine 57 Idiopathic Pulmonary Fibrosis 57 Completes Enrollment 57 plus gemcitabine 57 pulmonology portfolio 57 KRN# 57 Pivotal Study 57 relapsed refractory multiple myeloma 57 Presents Positive 57 J Am Acad 57 post operative ileus 57 Single Dose 57 Chronic Hepatitis C 57 YOUR LOCAL ANIMAL SHELTER 56 Clinical Trial Results 56 Fibrillex TM 56 Initiates Phase 56 Metastatic Melanoma 56 Phase III Clinical Trial 56 Myelofibrosis 56 II Clinical Trial 56 FDA Accepts 56 double blinded placebo 56 Daclizumab 56 RE LY 55 Phase IIIb 55 Epratuzumab 55 Receives Orphan Drug Designation 55 ongoing Phase 1b 55 phase Ib 55 Monotherapy 55 Hepatocellular Carcinoma 55 Heart Failure Patients 55 Arrhythmias 55 HGS ETR2 55 arterial hypertension 55 Renal Cell Carcinoma 55 Angiotensin II 54 dose escalation clinical 54 Tesetaxel 54 optic neuropathy 54 hyperglycaemia 54 phase IIb clinical 54 Patient Enrollment 54 FDA Oncologic Drugs 54 Acute Myocardial Infarction 54 Phase Ib II 54 metastatic castrate resistant 54 phase IIa 54 Peripheral neuropathy 54 Rotigotine 54 Phase III Trial 53 Metastatic Colorectal Cancer 53 Chronic Lymphocytic Leukemia 53 ThermoDox R 53 inhaled formulation 53 Drug Shows Promise 53 IMC #B 53 R bortezomib 53 Pralatrexate 53 Pulmonary hypertension 53 hyperkalemia 53 registrational trial 53 CR# vcMMAE 53 thrombotic disorders 53 HALTS 53 guanfacine 52 multi kinase inhibitor